Experimental Hematology Group - VHIO

VHIO’s Experimental Hematology Group conducts translational, pre-clinical and clinical research on hematological neoplasms of both lymphoid and myeloid origin. Our research team is composed of hematologists and biological scientists who work closely together to design, conduct and lead our programs.

VHIO 'on the ground' at ASH 2021: seeking out more effective

Novel liquid biopsy approach shows 30% increased sensitivity in

PDF) Regulation of B-Cell Receptor Signaling and Its Therapeutic

Experimental Therapeutics Group - VHIO

Tumor Immunology & Immunotherapy Group - VHIO

CARsgen Announces Formation of its Clinical Advisory Board

Carlota Pagès Geli - PHD Candidate - Vall d´Hebron Institute of

Experimental Hematology & Oncology

Cristina HERNANDEZ PhD Student in Experimental Hematology Group

Dr. Marta Crespo receives grant from the AECC Barcelona